June 12, 2009

EOP2a Returns – A Critical Milestone in the Regulatory Process

Very soon, FDA will restart its End of Phase 2a (EOP2a) meeting program during which sponsors and FDA collaborate often using modeling and simulation to analyze current data, refine clinical trial design, and to inform industry’s critical go/no-go decisions on projects.

READ MORE


April 14, 2009

Ted Grasela Lectures at Yale

Ted Grasela, president and CEO of Cognigen Corporation, presented The Changing Drug Development Paradigm and Implications for Pharmacoepidemiology at Yale University on April 9, 2009.

READ MORE


March 26, 2009

Jill Fiedler-Kelly Discusses Pharmacometric Careers

READ MORE


March 25, 2009

Kerfuffle! Published in Journal of Clinical Pharmacology

READ MORE


March 24, 2009

Now Approved for Human Use — Cognigencorp.com

When Cognigen wanted to redesign its website, we partnered with a local Buffalo company - Crowley Webb and Associates. We wanted an innovative, non-traditional website that everyone would take an interest in. Here it is!

READ MORE


November 17, 2008

Ted Grasela is awarded 2008 AAPS Fellow status

The American Association of Pharmaceutical Scientists (AAPS), at its 2008 Annual Meeting held in Atlanta, Georgia, named Ted Grasela, PharmD, PhD, a 2008 AAPS Fellow. Dr. Grasela was nominated and selected for this prestigious award based on more than 20 years of sustained remarkable scholarly and research contributions to the pharmaceutical sciences in modeling and simulation.

READ MORE


Page 9 of 9 pages. ‹ First  < 7 8 9